Alysia Kretschmar
Family · Dearborn, MINPI 1326682956
Payments from drug & device makers
Across 218 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$594
- AstraZeneca$391
- Novartis$360
- Kiniksa Pharmaceuticals, Ltd.$272
- Merck$272
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$215
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,66097%
- Education$1143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 43 | $594 |
| AstraZeneca | 22 | $391 |
| Novartis | 20 | $360 |
| Kiniksa Pharmaceuticals, Ltd. | 12 | $272 |
| Merck | 18 | $272 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $215 |
| Novo Nordisk | 14 | $191 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $180 |
| Exact Sciences | 8 | $173 |
| Lilly USA, LLC | 9 | $160 |
| Amgen | 9 | $148 |
| Chiesi USA, Inc. | 4 | $97 |
| AbbVie | 4 | $78 |
| Pfizer | 4 | $75 |
| Edwards Lifesciences | 2 | $73 |
| Alnylam Pharmaceuticals Inc. | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 4 | $54 |
| Philips North America LLC | 3 | $52 |
| GSK | 3 | $50 |
| Heartflow, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Ascendis Pharma Endocrinology Inc | 2 | $28 |
| Irhythm Technologies, Inc. | 1 | $25 |
| Bardy Diagnostics, Inc. | 2 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Bayer | 1 | $22 |
| Boston Scientific | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Abiomed | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$3,774 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 23 | $582 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $263 |
| Omeprazole | 15 | $260 |
| Gabapentin | 19 | $240 |
| Pantoprazole Sodium | 11 | $174 |
| Methylprednisolone | 32 | $171 |
| Losartan Potassium | 16 | $171 |
| Metoprolol Succinate | 11 | $101 |
| Ciprofloxacin Hcl | 12 | $53 |
| Lisinopril | 13 | $48 |
| Azithromycin | 21 | $46 |
| Fluconazole | 13 | $35 |
| Tramadol Hcl | 13 | $30 |
| Prednisone | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other family in Dearborn
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.